2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia LY3875383, Placebo - Hypertriglyceridemia | Phase 1 | Terminated | Eli Lilly and Company | 41 | 2022-11-14 | 2025-06-04 |
| A First in Human Study of STT-5058, an Antibody That Binds ApoC3 STT-5058, Placebo - Hypertriglyceridemia | Phase 1 | Terminated | Staten Biotechnology BV | 93 | 2020-05-26 | 2023-01-23 |
Dyslipidemias (2) · Hyperlipidemias (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Eli Lilly and Company (1) · Staten Biotechnology BV (1)
Singapore (1) · United Kingdom (1)